1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Radiation Therapy Equipment Industry

World Radiation Therapy Equipment Industry

  • January 2015
  • -
  • Global Industry Analysts
  • -
  • 360 pages

This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 48 companies including many key and niche players such as -

Accuray Incorporated
BrainLab
Elekta AB
GE Healthcare
Hitachi America

Table Of Contents

World Radiation Therapy Equipment Industry



I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Linear Accelerator I-3
Treatment Planning System I-4
Radiation Therapy Simulator I-4


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW II-1
Global Market for Radiotherapy - A Synopsis II-1
Radiation Therapy Equipment and Software Market Bounces Back
from Recession II-2
Table 1: Healthcare Spending as a Percentage of GDP in Select
Countries (includes corresponding Graph/Chart) II-3

Table 2: Per-Capita Healthcare Expenditure in Select Regions
(2013) (includes corresponding Graph/Chart) II-4
Current and Future Analysis II-5
North America - The Most Advanced and Dominant Global Market
for Radiotherapy II-6
US Leads in Penetration of LINACs II-6
Table 3: Installed Base of Linacs Per Million Inhabitants
for Select Geographic Regions/ Countries (2013) (includes
corresponding Graph/Chart) II-7
Developing Nations Offer Lucrative Opportunities II-8
Table 4: Top 20 Countries with the Highest Healthcare
Spending as a Percentage of GDP (2012) (includes
corresponding Graph/Chart) II-9
Asia-Pacific - A Highly Promising Market II-9

2. MARKET DYNAMICS II-11
Expanding Aging Population Raises Risk of Cancer, Drives
Demand for Radiation Therapy Solutions II-11
Table 5: Global Population Statistics for the 65+ Age Group
(2013) (includes corresponding Graph/Chart) II-12

Table 6: Elderly Population (60+ Years) as a Percentage of
the Total Population (2012 and 2050) (includes corresponding
Graph/Chart) II-13

Table 7: Life Expectancy at Age 60 and 80 Years -
(2010-2015), (2020-2025) and (2045-2050) (includes
corresponding Graph/Chart) II-13
Replacement Sales Drive Radiotherapy Market in Developed Markets II-14
Table 8: Percentage of Patients Provided Radiation Therapy in
Developed Markets (2013) (includes corresponding Graph/Chart) II-15

Table 9: Global Installed Base of LINACs (2013): Percentage
Share Breakdown by Volume of Units Installed for North
America, Europe, Asia Pacific (Including Japan) and Middle
East, South America, and Africa (includes corresponding
Graph/Chart) II-15
Improving Healthcare Expenditure Turbo Charges Demand II-16
Table 10: Per-Capita Healthcare Expenditure in Select Regions
(2013) (includes corresponding Graph/Chart) II-16
External Beam Radiation Therapy Equipment Corners Lion's Share
of Market II-17
Table 11: Global Radiation Therapy Equipment Market by Type
(2014): Market Share Breakdown of Sales Revenues for External
Beam Radiation Therapy (EBRT), Brachytherapy, and Others
(includes corresponding Graph/Chart) II-17
LINACS Increasingly Replace Conventional Equipment II-17
Demand for Oncology Information Systems (OIS) on Rise II-18
Data-Intensive Radiation Oncology Promotes OIS Connection to
EHRs II-18
Treatment Planning - Grows in Significance II-19
Need for Boosting Productivity of Existing Cancer Care Centers
Drives Demand for New Technologies II-19
Technological Innovations Improve Treatment Accuracy II-20
Personalized Radiation Therapy - The Way Forward II-20
Hospitals Focus on Buying IMRT-Capable LINACs II-21
Types of IMRT II-22
Rotational IMRT Gains Popularity II-22
Stereotactic Radio Surgery - A Treatment with Rising Preference II-22
Adaptive Radiation Therapy (ART) Gains Significance II-23
IGRT Gaining Ground II-23
Shortage of Medical Professionals and Systems - A Major Obstacle II-24
Patient Comfort - A Significant Concern Affecting Treatment
Accuracy II-24

3. PROTON THERAPY - AN INSIGHT II-25
Proton Therapy - Revolutionizing the Industry II-25
Table 12: World Recent Past, Current and Future Analysis for
Proton Therapy by Geographic Region - US, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-26

Table 13: World 7-Year Perspective for Proton Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe, Asia-Pacific (excluding Japan), and Rest
of World Markets for Years 2014 and 2020 (includes
corresponding Graph/Chart) II-27
IMPT - The Future of Proton Therapy II-27
High Cost - A Barrier to Adoption II-28
Technological Advancement to Lower Cost of Therapy II-28

4. COMPETITION II-29
Competitive Landscape II-29
Table 14: Leading Global Players in Radiation Therapy
Equipment Market (2013): Percentage Share Breakdown by Sales
for Varian, Elekta, Accuray, Siemens, and Others (includes
corresponding Graph/Chart) II-30
Exit of Siemens Healthcare Opens Doors for Windfall Gains II-30
Table 15: Siemens Healthcare Worldwide Installed Base of
Linear Accelerators (2013) (includes corresponding
Graph/Chart) II-31
Competition in the LINAC Segment II-31
Table 16: Leading Players in Global LINAC Market (2012):
Percentage Share Breakdown by Volume of Units Installed for
Varian, Elekta, Siemens and Others (includes corresponding
Graph/Chart) II-32
Stereotactic Radiosurgery Systems (SRS) - Market Scenario II-32
Table 17: Leading Players in SRS/SBRT Market (2013):
Percentage Share Breakdown by Volume Sales for Elekta,
BrainLab, Accuray and Others (includes corresponding
Graph/Chart) II-32
Proton Therapy Equipment Market Marked by Intense Competition II-32
Table 18: Leading Global Players in Proton Therapy Market
(2013): Percentage Share Breakdown by Operational Installed
Base for IBA, Hitachi, Mitsubishi, Varian and Sumitomo
(includes corresponding Graph/Chart) II-33
Competitive Landscape in Treatment Planning Systems Market II-33
Table 19: Global Treatment Planning Systems Market by
Leading Players (2013): Market Share Breakdown for Installed
Base for Elekta/Nucletron, Philips, Varian and Others
(includes corresponding Graph/Chart) II-34

5. CANCER - A GLOBAL CONCERN II-35
Cancer Incidence - Statistics on New Cases II-35
Table 20: Worldwide Incidence of Cancer (2013, 2020 and 2030):
Number of New Cases Diagnosed (includes corresponding
Graph/Chart) II-35

Table 21: New Cancer Cases in the World by Affected Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-36

Table 22: Global Cancer Incidence by Income Group: 2012 (in
Thousands) (includes corresponding Graph/Chart) II-37

Table 23: Cancer Incidence in High Income Countries by Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-37

Table 24: Cancer Incidence in Upper Middle Income Countries
by Site: 2012 (in Thousands) (includes corresponding
Graph/Chart) II-38

Table 25: Cancer Incidence in Lower Middle Income Countries
by Site: 2012 (in Thousands) (includes corresponding
Graph/Chart) II-39

Table 26: Cancer Incidence in Low Income Countries by Site:
2012 (in Thousands) (includes corresponding Graph/Chart) II-40
Cancer Incidence in Developing Countries II-40
Cancer in Asia II-41
Cancer Cases - Mortality Rates II-41

6. RADIATION THERAPY: AN OVERVIEW II-42
Radiation Therapy - A Panacea for all Cancer Diseases II-42
Milestones in Evolution of Cancer Care Technologies II-43
Treatment Scenario II-43
Table 27: Major Body Sites for Administration of
Radiotherapy: Percentage Breakdown of Frequency of
Application of Radiation Treatment for Breast, Prostate,
Lung, Head and Neck, and Other Body Sites (includes
corresponding Graph/Chart) II-44
Radiation Therapy Treatment Team II-44
Types of Radiation Therapy II-44
External Beam Radiation Therapy (EBRT/XRT) or Teletherapy II-45
Conventional External Beam Radiotherapy II-45
Stereotactic Radiation II-45
Particle Therapy or Proton Therapy II-45
Auger Therapy II-46
Internal Beam Radio Therapy/Brachytherapy II-46
More About Brachytherapy II-46
Technical Scope of Brachytherapy II-47
Systemic Radioisotope Therapy (RIT) II-47
Radiation Therapy for Treating Oral Cancer II-47
Other Forms of Radiation Therapy II-48
Photoradiation Therapy (PRT) II-48
Photodynamic Therapy (PDT) II-48
Cost of Radiation Therapy II-48
Limitations of Conventional Radiation Therapy Techniques II-48
Overview of Radiotherapy Equipment II-49
External Beam Therapy Devices II-49
CyberKnife II-49
Gamma Knife II-49
TomoTherapy II-50
LINACs II-50
Comparison of Select Radiotherapy Systems II-50
Proton Therapy Devices II-51

7. PRODUCT OVERVIEW II-52
Introduction II-52
Landmarks in Evolution of Cancer Care II-52
Linear Accelerator II-52
Accelerator - Down to Nuts and Bolts II-52
Clinical Demands and Device Characteristics II-53
Dual X-ray Energy Linear Accelerator - Numerous Energy
Offerings II-54
Price - A Direct Functionality of Features II-54
Beam Energy and Dose Rates - Deciding Factors II-54
Isocentric Units - The Prevalent Form in Accelerators II-54
Subsystem Design Factors II-55
Bending Magnet Systems - For Smooth Functioning II-55
Dosimetry System - Regulating the Radiation Dosage II-55
Beam Steering Systems - Directing the Flow II-56
Cobalt-60 II-56
Characteristics of Cobalt-60 Machines II-56
Major features of Cobalt-60 Radioisotope II-56
Competitive Edge: Cobalt 60 Units vs. Linear Accelerators II-57
Comparative Assessment of Cobalt-60 Teletherapy Units and
Linear Accelerators II-57
Benefits of LINACs over Cobalt 60 Units II-58
Treatment Planning System: An Innovative Technique in
Radiation Therapy II-58
Radiation Therapy Simulator II-59
CT Simulation Systems II-59
Major Systems of Radiation Therapy Simulator II-60
Mechanical Systems II-60
Principles of Operations II-61

8. RADIOTHERAPY ACCESSORIES II-62
Introduction II-62
Tumor Localization and Treatment Simulation Devices II-62
Patient Restraint and Repositioning Devices II-62
Different Types of Patient Restraint and Repositioning Devices II-63
Patient Targeting System II-63
Field-Shaping Devices II-63
Dose-Modifying Devices II-64
Treatment Setup and Delivery Devices II-65
Breast Bridge with a Rolling-Ball Angle Inclinometer II-65
Squeeze Bridge Device II-65
Beam Alignment Device II-66
Arm Board II-66
Tilt Board II-66
Shoulder Reactor II-66
Mylar Window Table Insert II-66
Clamps II-66
Treatment Verification and Quality Assurance Devices II-66
Need for Surgery and Radiotherapy Likely to Diminish II-67

9. CANCER THERAPY - EPIDEMIOLOGY II-68
Four Progressive Stages of Cancer II-68
Types of Cancer II-68
Breast Cancer II-69
Treatment Options II-69
Major Developments in the Treatment Area of Breast Cancer II-69
Colorectal Cancer II-70
Prostate Cancer II-70
Pancreatic Cancer II-71
Cervical Cancer II-71
Esophageal Cancer II-71
Lung Cancer II-71
Treatment Options Available II-72
Technological Developments II-72
Cures II-72
Enhanced Therapies II-72
Prevention and Public Awareness II-72
Better Screening and Earlier Detection II-72
Other Emerging Therapies II-73

10. CANCER TREATMENT - A COST ANALYSIS II-74
Table 28: Cancer Treatment Costs by Modality II-74
Medicare and Medicaid Reimbursement II-74
Coverage II-75
Coding II-75
Payment II-75

11. NEW FRONTIERS IN RADIATION THERAPY II-76
Increasing Role of Imaging in Treatment Planning II-76
MRI to Attain Optimum Outcomes II-76
Positron Emission Tomography II-76
Convergence of PET and CT Images for Treatment Planning II-76
Dynamic contrast-enhanced CT/MRI II-77
Copper(II)-diacetyl-bis(N4-methylthiosemicarbazone) PET (Cu-
ATSM PET) II-77
Four-Dimensional CT Scanning II-77
4D Adaptive Radiation Therapy - Adds a New Dimension II-77
MRI-Linacs - To Revolutionize Cancer Care II-78
Nano Particles in Cancer Treatment II-78
Microbeam Radiation Therapy Revisited II-79
Unleashing the Power of Plasma II-79
ION Beam Therapy Gains Attention II-80
Volumetric Modulated Arc Therapy (VMAT) II-80
Mobetronâ„¢ - Radiation Therapy on the Wheels II-80
3-D Conformal Radiation Therapy: A New Technology II-81
World's First 3-D Image-Guided Radiation Therapy System from
Elekta II-81
Evolving Technology Arms TomoTherapy with an Edge over
Competition II-81
High Dose Radiation Treatment Found to Reduce Side Effects in
Prostate Cancer Treatment II-82

12. PRODUCT INNOVATIONS/INTRODUCTIONS II-83
National Institute for Health and Care Excellence Introduces
INTRABEAM radiotherapy II-83
IBA Inks Collaboration Agreement with Mobius Medical Systems II-83
Mirada Medical Enters into Agreement with RefleXion Medical
for Research Collaboration II-83
Radyalis and NVIDIA Announce Research Collaboration II-83
IBA Releases OmniPro I'mRT + Software II-83
Elekta Launches Advanced Versa HD Linear Accelerator System II-83
Ion Beam Applications (IBA) Unveils COMPASS 3.0 Plan
Verification System II-84
Alfred Health's WBRC Introduces Brainlab ExacTrac Adaptive
Gating System for Cancer Therapy II-84
Elekta Unveils New Monaco 5.0 Fully Integrated Radiation
Treatment Planning System II-84
Accuray Launches New TomoTherapy® H™ Series Technology II-84
Accuray and MIM Software to Launch Co-branded Version of
Mobile MIM 3.0 II-84
MIM Launches Upgraded Mobile MIM 3.0 II-84
Elekta Launches New Monaco® 3.0 DCA Treatment Planning System II-84

13. RECENT INDUSTRY ACTIVITY II-85
iCAD Takes Over Radion and DermEbx II-85
Elekta Gains Approval from Japanese Ministry of Health for
Versa HD II-85
Elekta Gains U.S. FDA 510(k) Approval for new Versa HD System II-85
The Christie NHS Foundation Trust Joins Consortium for
Developing MRI-guided Radiation Therapy System II-85
University Medical Center Installs First-ever MRI-guided
Radiation Therapy System II-85
The Netherlands Cancer Institute-Antoni van Leeuwenhoek
Hospital Joins Elekta and Royal Philips Consortium II-85
University of Texas MD Anderson Cancer Center Trust Joins
Elekta and Royal Philips Consortium II-86
Oncology Services International Takes Over Upstate Linac Services II-86
RTS Acquires OnCure Holdings II-86
Equra Health and Elekta Ink Long-term Agreement II-86
Radiation Oncology Resources and McKesson Specialty Health
Sign Multi-year Agreement II-86
Elekta Secures Order for Versa HD Systems from St. James's
Institute of Oncology II-86
RaySearch Laboratories and Hitachi Medical Sign Distribution
Agreement II-87
Spire Healthcare Enters into Partnership with Elekta II-87
RaySearch Laboratories Announces Research Collaboration with
Brainlab II-87
Oncology Services International Enters into Partnership with
D3 Oncology Solutions II-87
Oncology Systems and IBA Dosimetry Sign Distribution Agreement II-87
Ion Beam Applications Partners Apollo Hospitals to Establish
Proton Therapy Center II-87
Froedtert and The Medical College of Wisconsin Clinical Cancer
Center Joins Consortium for Developing MRI-guided Radiation
Therapy System II-88
Sunnybrook Health Sciences Centre Joins Consortium for
Developing MRI-guided Radiation Therapy System II-88
Varian Obtains FDA 510(k) Authorization for RapidPlan
Radiotherapy Treatment Planning Tool II-88
Varian Medical Systems Enters into Partnership with Siemens
Healthcare II-88
Accuray to Take Over Morphormics II-88
e2v Bags Contract from Accuray II-88
Northern Centre for Cancer Care to Purchase TrueBeamâ„¢ Devices
from Varian II-89
Elekta Signs MoU with MSM-MEDIMPEX II-89
Institut Curie Selects Radiotherapy Systems of Varian Medical
Systems II-89
Varian Medical Systems Establishes Subsidiary in South Korea II-89
NHS Supply Chain Enters into Agreement with Elekta II-89
Elekta Takes Over Radon II-89
Varian Bags Order to Equip Proton Therapy Facility II-89
Varian Medical Systems Secures SFDA Approval for UNIQUEâ„¢
Medical Linear Accelerator II-90
Mevion Medical Systems Receives FDA Approval for MEVION S250
Proton Therapy System II-90
Accuray Inks Agreement with German Cancer Research Center II-90
Nordion Announces Launch of Gamma Centre of Excellence II-90

14. FOCUS ON SELECT KEY PLAYERS II-91
Accuray Incorporated (US) II-91
BrainLab (Germany) II-91
Elekta AB (Sweden) II-91
Nucletron B.V. (The Netherlands) II-92
GE Healthcare (UK) II-92
Hitachi America (US) II-93
IBA Group (Belgium) II-93
Mitsubishi Electric Corporation (Japan) II-94
Nordion, Inc. II-94
Philips Healthcare (US) II-95
RaySearch (Sweden) II-95
Sumitomo Heavy Industries Ltd. (Japan) II-95
Varian Medical Systems, Inc. (US) II-96

15. GLOBAL MARKET PERSPECTIVE II-97
Table 29: World Recent Past, Current and Future Analysis for
Radiation Therapy Equipment by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East and
Africa and Latin American Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) II-97

Table 30: World Historic Review for Radiation Therapy
Equipment by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Africa and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-98

Table 31: World 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East and Africa and Latin American Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) II-99

Table 32: World Recent Past, Current and Future Analysis for
Linear Accelerators by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Africa
and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2013 through 2020
(includes corresponding Graph/Chart) II-100

Table 33: World Historic Review for Linear Accelerators by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Africa and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-101

Table 34: World 15-Year Perspective for Linear Accelerators by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Africa and Latin American Markets for Years
2006, 2014 and 2020 (includes corresponding Graph/Chart) II-102

Table 35: World Recent Past, Current and Future Analysis for
Treatment Planning Systems by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East and
Africa and Latin American Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) II-103

Table 36: World Historic Review for Treatment Planning Systems
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Africa and Latin American
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-104

Table 37: World 15-Year Perspective for Treatment Planning
Systems by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East and Africa and Latin American Markets for
Years 2006, 2014 and 2020 (includes corresponding Graph/Chart) II-105

Table 38: World Recent Past, Current and Future Analysis for
Radiation Therapy Simulators by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle
East and Africa and Latin American Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2013 through 2020 (includes corresponding Graph/Chart) II-106

Table 39: World Historic Review for Radiation Therapy
Simulators by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Africa and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-107

Table 40: World 15-Year Perspective for Radiation Therapy
Simulators by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Africa and Latin American
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) II-108


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Market Overview III-1
Radiation Therapy Market - An Insight III-1
Table 41: US Market for Hospital Cancer Therapies (2004 and
2015: Percentage Breakdown of Revenues by Treatment Type -
Surgery, Chemotherapy Drugs, Radiation Therapy,
Biotechnology-Based Drugs, and Others (includes
corresponding Graph/Chart) III-2
Replacements Drive Unit Installations III-3
Table 42: US Linacs Installed Base (2013): Percentage
Share Breakdown by Age of Equipment (includes
corresponding Graph/Chart) III-3
EHR Incentive Program Promotes Improvements in Efficiencies III-3
Recession Brings in More Worries for Cancer Patients III-4
Demographics Drive Radiation Therapy Market III-4
IMRT Market III-5
Innovations Propel Market Growth III-5
Demand on Rise for Treatment Planning Software III-6
Competition III-6
Table 43: Leading Players in the North American Radiation
Therapy Equipment Market (2013): Market Share Breakdown by
Volume Sales for Accuray, Elekta, and Varian (includes
corresponding Graph/Chart) III-7

Table 44: Leading Players in the North American Radiation
Therapy Equipment Market (2013): Market Share Breakdown by
Installed Base for Accuray, Elekta, Siemens and Varian
(includes corresponding Graph/Chart) III-7
Cancer Stats III-7
Table 45: New Cancer Cases in the US by Gender and Affected
Site: 2014E III-8

Table 46: New Cancer Cases in Males in US by Leading Site:
2014E (includes corresponding Graph/Chart) III-10

Table 47: New Cancer Cases in Females in US by Leading
Site: 2014E (includes corresponding Graph/Chart) III-11

Table 48: New Cancer Cases in US by State: 2014E III-12

Table 49: Incidence of Cancer for All Body Sites by Gender and
Age Group in the US (2013): New Cancer Cases for Males and
Females for the Age groups Under 45 years; 45 years and
Above; Under 65 years; and 65 years and Above (includes
corresponding Graph/Chart) III-14
Cancer Mortality Statistics III-15
Table 50: Cancer Related Deaths in the US by Gender and
Body Site: 2014E III-15

Table 51: Cancer Related Deaths in Males in US by Leading
Site: 2014E (includes corresponding Graph/Chart) III-17

Table 52: Cancer Related Deaths in Females in US by Leading
Site: 2014E (includes corresponding Graph/Chart) III-18

Table 53: Number of Deaths Related to Major Types of Cancer
in US by State: 2014E III-19

Table 54: Cancer Related Deaths in US by Age Group: 2012
(includes corresponding Graph/Chart) III-20
Reimbursement Scenario III-21
Coding III-21
Table 55: Reimbursement for Select Radiation Therapy Codes III-22
Product Introductions III-23
Strategic Corporate Developments III-23
Key Players III-26
B.Market Analytics III-28
Table 56: US Recent Past, Current and Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-28

Table 57: US Historic Review for Radiation Therapy Equipment
by Product Segment - Linear Accelerator, Treatment Planning
Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-29

Table 58: US 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-30

Table 59: US Recent Past, Current and Future Analysis for
Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-31

2. CANADA III-32
A.Market Analysis III-32
Current and Future Analysis III-32
Market Led by Replacement III-32
Cancer Statistics in Canada III-33
Table 60: New Cancer Cases in Canada by Gender and Affected
Site: 2014E (includes corresponding Graph/Chart) III-33

Table 61: New Cancer Cases in Canada by Province: 2014E
(includes corresponding Graph/Chart) III-34

Table 62: New Cancer Cases in Canada by Age Group: 2014E
(includes corresponding Graph/Chart) III-35

Table 63: Cancer Related Deaths in Canada by Gender and
Affected Site: 2014E (includes corresponding Graph/Chart) III-36

Table 64: Cancer Related Deaths in Canada by Province:
2014E (includes corresponding Graph/Chart) III-37

Table 65: Cancer Related Deaths in Canada by Age Group:
2014E (includes corresponding Graph/Chart) III-38
Product Introductions III-39
Strategic Corporate Development III-39
Key Player III-39
B.Market Analytics III-40
Table 66: Canadian Recent Past, Current and Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-40

Table 67: Canadian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-41

Table 68: Canadian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-42

3. JAPAN III-43
A.Market Analysis III-43
Current and Future Analysis III-43
Radiation Therapy Market - An Overview III-43
Table 69: Cancer Related Deaths by Age Groups: 2013
(includes corresponding Graph/Chart) III-44

Table 70: Japanese Radiation Therapy Equipment Market by
Leading Players (2013): Market Share Breakdown by New
Orders for Accuray, BrainLab, Elekta, and Varian (includes
corresponding Graph/Chart) III-45
Strategic Corporate Developments III-45
Select Players III-45
B.Market Analytics III-47
Table 71: Japanese Recent Past, Current and Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-47

Table 72: Japanese Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-48

Table 73: Japanese 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-49

Table 74: Japanese Recent Past, Current and Future Analysis
for Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-50

4. EUROPE III-51
A.Market Analysis III-51
Current and Future Analysis III-51
Under-provision of Radiotherapy Units Offer New Opportunities III-51
Table 75: Europe Market for Radiation Therapy Equipment
(2013): Percentage Share Breakdown by Number of Treatment
Facilities for Germany, France, Italy, Spain and Others
(includes corresponding Graph/Chart) III-52

Table 76: Europe Market for Radiation Therapy Equipment
(2013): Percentage of Patients Receiving Radiation Therapy
across Select Countries (includes corresponding
Graph/Chart) III-52
Cancer Stats III-52
Table 77: Cancer Incidence in Europe by Site: 2012 (in
Thousands) (includes corresponding Graph/Chart) III-53

Table 78: Number of New Cancer Cases in Europe (2012-2030)
(In Million) (includes corresponding Graph/Chart) III-54
Key Players III-54
Table 79: Leading Players in European Radiation Therapy
Market (2013): Percentage Market Share Breakdown for
Elekta, Varian, and Others (includes corresponding
Graph/Chart) III-54
B.Market Analytics III-55
Table 80: European Recent Past, Current and Future Analysis
for Radiation Therapy Equipment by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-55

Table 81: European Historic Review for Radiation Therapy
Equipment by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-56

Table 82: European 15-Year Perspective for Radiation Therapy
Equipment by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-57

Table 83: European Recent Past, Current and Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-58

Table 84: European Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-59

Table 85: European 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-60

Table 86: European Recent Past, Current and Future Analysis
for Proton Therapy Market with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-61

4a. FRANCE III-62
A.Market Analysis III-62
Current and Future Analysis III-62
Strategic Corporate Development III-62
B.Market Analytics III-63
Table 87: French Recent Past, Current and Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-63

Table 88: French Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-64

Table 89: French 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-65

4b. GERMANY III-66
A.Market Analysis III-66
Current and Future Analysis III-66
Strategic Corporate Development III-66
Brainlab - A Key German Player III-66
B.Market Analytics III-67
Table 90: German Recent Past, Current and Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-67

Table 91: German Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-68

Table 92: German 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-69

4c. ITALY III-70
A.Market Analysis III-70
Current and Future Analysis III-70
B.Market Analytics III-70
Table 93: Italian Recent Past, Current and Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-70

Table 94: Italian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-71

Table 95: Italian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-72

4d. THE UNITED KINGDOM III-73
A.Market Analysis III-73
Current and Future Analysis III-73
Product Introductions III-73
Strategic Corporate Developments III-73
B.Market Analytics III-75
Table 96: The UK Recent Past, Current and Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-75

Table 97: The UK Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-76

Table 98: The UK 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-77

4e. SPAIN III-78
A.Market Analysis III-78
Current and Future Analysis III-78
B.Market Analytics III-78
Table 99: Spanish Recent Past, Current and Future Analysis for
Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-78

Table 100: Spanish Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-79

Table 101: Spanish 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-80

4f. RUSSIA III-81
A.Market Analysis III-81
Current and Future Analysis III-81
Strategic Corporate Development III-81
B.Market Analytics III-82
Table 102: Russian Recent Past, Current and Future Analysis
for Radiation Therapy Equipment by Product Segment - Linear
Accelerator, Treatment Planning Systems, and Radiation
Therapy Simulators Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2013 through
2020 (includes corresponding Graph/Chart) III-82

Table 103: Russian Historic Review for Radiation Therapy
Equipment by Product Segment - Linear Accelerator, Treatment
Planning Systems, and Radiation Therapy Simulators Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-83

Table 104: Russian 15-Year Perspective for Radiation Therapy
Equipment by Product Segment - Percentage Breakdown of Value
Sales for Linear Accelerator, Treatment Planning Systems,
and Radiation Therapy Simulators Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-84

4g. REST OF EUROPE III-85
A.Market Analysis III-85
Current and Future Analysis III-85
Product Introductions III-85
Strategic Corporate Developments III-85
Key Players III-86
B.Market Analytics III-89
Table 105: Rest of Europe Recent Past, Current and Future
Analysis for Radiation Therapy Equipment by Product Segment -
Linear Accelerator, Treatment Planning Systems, and
Radiation Therapy Simulators Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) III-89

Table 106: Rest of Europe Historic Review for Radiation
Therapy Equipment by Product Segment - Linear Accelerator,
Treatment Planning Systems, and Radiation Therapy Simulators
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-90

Table 107: Rest of Europe 15-Year Perspective for Radiation
Therapy Equipment by Product Segment - Percentage Breakdown
of Value Sales for Linear Accelerator, Treatment Planning
Systems, and Radiation Therapy Simulators Markets for Years
2006, 2014 and 2020 (includes corresponding Graph/Chart) III-91

5. ASIA-PACIFIC III-92
A.Market Analysis III-92
Current and Future Analysis III-92
Asia - A Potential Market for Radiation Therapy Equipment III-92
Table 108: Number of Beds in Public and Private Sector
Hospitals in China, India and Indonesia (2015) (includes
corresponding Graph/Chart) III-93

Table 109: Population Statistics in Asia (Including Japan) and
Percentage of Population Aged Above 65 Years (includes
corresponding Graph/Chart) III-94

Table 110: Installed Base of Clinical Accelerators in Asia
(includes corresponding Graph/Chart) III-95

Table 111: Market Potential for Clinical Accelerators in
Asia (Including Japan): Calculated in Terms of Thousands
of People Per Accelerator (includes corresponding
Graph/Chart) III-96
Cancer Statistics in Asia-Pacific III-96
Table 112: Cancer Incidence in Asia-Oceania by Site: 2011
(in Thousands) (includes corresponding Graph/Chart) III-97
Competitive Scenario III-97
Table 113: Asia-Pacific Market for Radiotherapy Equipment
and Software by Leading Players (2013): Market Share
Breakdown by New Orders for Accuray, Elekta, Varian, and
Others (includes corresponding Graph/Chart) III-98
B.Market Analytics III-99
Table 114: Asia-Pacific Recent Past, Current and Future
Analysis for Radiation Therapy Equipment by Geographic
Region - China, India and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-99

Table 115: Asia-Pacific Historic Review for Radiation
Therapy Equipment by Geographic Region - China, India and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2006 through
2012 (includes corresponding Graph/Chart) III-100

Table 116: Asia-Pacific 15-Year Perspective for Radiation
Therapy Equipment by Geographic Region - Percentage
Breakdown of Value Sales for China, India and Rest of
Asia-Pacific Markets for Years 2006, 2014 and 2020 (includes
corresponding Graph/Chart) III-101

Table 117: Asia-Pacific Recent Past, Current and Future
Analysis for Radiation Therapy Equipment by Product Segment -
Linear Accelerator, Treatment Planning Systems, and
Radiation Therapy Simulators Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) III-102

Table 118: Asia-Pacific Historic Review for Radiation
Therapy Equipment by Product Segment - Linear Accelerator,
Treatment Planning Systems, and Radiation Therapy Simulators
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-103

Table 119: Asia-Pacific 15-Year Perspective for Radiation
Therapy Equipment by Product Segment - Percentage Breakdown
of Value Sales for Linear Accelerator, Treatment Planning
Systems, and Radiation Therapy Simulators Markets for Years
2006, 2014 and 2020 (includes corresponding Graph/Chart) III-104

Table 120: Asia-Pacific Recent Past, Current and Future
Analysis for Proton Therapy Market with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-105

5a. CHINA III-106
A.Market Analysis III-106
Current and Future Analysis

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis - Opportunity Analysis and Forecast to 2025

OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis - Opportunity Analysis and Forecast to 2025

  • $ 9 495
  • Industry report
  • June 2016
  • by Global Data

OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis - Opportunity Analysis and Forecast to 2025 Summary The IPF therapeutic market is currently dominated by the only two drugs that have gained marketing ...

Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies

Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies

  • $ 6 995
  • Industry report
  • June 2016
  • by GBI Research

Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies Summary Diabetes is a common ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.